The insights from SARS-CoV-2 antibody treatment for future emerging infectious diseases

Early treatment with these antibodies can reduce COVID-19-related hospitalisation or death in patients at high risk.1–3 These antibodies can also provide targeted prophylaxis for individuals at high risk, and interrupt transmission of viruses in populations.4 A major concern of SARS-CoV-2 antibodies...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet infectious diseases 2024-01, Vol.24 (1), p.2-3
Hauptverfasser:	Wang, Yeming, Cao, Bin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Cell membranes COVID-19 Disease prevention Disease transmission Drugs Infectious diseases Inhalation Oral administration Prophylaxis Respiration Ritonavir Severe acute respiratory syndrome coronavirus 2 Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!